Our Issue Briefs
Learn more about our arthritis advocacy position on a number of hot issues from surprise billing to Step Therapy.
Each year thousands of patients seeking treatment for arthritis are met with unexpectedly large medical bills, due to confusing relationships between insurance providers, health care providers and health care facilities. Learn more about surprise billing here. Learn more.
Have you or someone you love been forced to endure excessive pain due to step therapy? Our survey of 1,400 patients found that over 50 percent of patients reported having to try two or more drugs prior to getting the one their doctor originally recommended. Learn more.
Many patients seeking medication vital to their arthritis treatment are held up by prior authorization, a process in which a physician must submit tedious paper work before writing a prescription. Find out what can be done to simplify this process. Learn more.
Insurance Plan Transparency
Getting proper arthritis treatment through an insurance provider can be difficult due to prior authorization, cost sharing and step therapy requirements. Find out why insurance plan transparency is so critical to arthritis patients. Learn more.
Out of Pocket Costs
Learn more about our advocacy position on the issue of out of pocket costs, including the current survey data trends, the solutions we endorse and current legislative trends.
Mid-Year Plan Changes
Learn more about our advocacy position on the issue of mid-year insurance plan changes, including the solutions we endorse and current legislative trends.
Learn more about our advocacy position on the issue of network adequacy, including what it is, the solutions we endorse and current legislative trends.
Learn more about why we advocate for individual health insurance market stabilization, including the solutions we endorse and current legislative trends.
Joint Matters E-Newsletter
Subscribe to Joint Matters: A Newsletter for Health Care Providers and Researchers. Each quarter, we help you catch up on everything that’s newsworthy in the field of arthritis.